A recent study published in the journal Cardiovascular Drugs and Therapy found that 93 million U.S. adults who are overweight or obese may be eligible for treatment with semaglutide, a weight loss medication known under the brand name Wegovy.
The study, led by researchers from the University of California, Irvine, projected that the use of semaglutide could result in 43 million fewer people with obesity, and prevent up to 1.5 million heart attacks, strokes, and other adverse cardiovascular events over 10 years.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it works by mimicking the effects of GLP-1, a hormone that helps control appetite and blood sugar levels. Semaglutide is currently approved by the FDA for the treatment of type 2 diabetes, and it has been shown to be effective in helping people lose weight.
The study from UC Irvine found that semaglutide could have a significant impact on the prevalence of obesity and cardiovascular disease in the United States. The researchers estimated that if all eligible adults took semaglutide, the number of people with obesity would decrease by 43 million and the number of heart attacks, strokes, and other adverse cardiovascular events would decrease by 1.5 million over 10 years.
The study’s findings suggest that semaglutide could be a valuable tool for preventing obesity and cardiovascular disease. However, more research is needed to confirm these findings and to determine the long-term safety and efficacy of semaglutide for weight loss.
Here are some other key points from the study:
- Semaglutide was found to be safe and effective for weight loss in adults with obesity.
- Semaglutide was associated with a significant reduction in the risk of heart attacks, strokes, and other adverse cardiovascular events.
- Semaglutide could potentially benefit millions of U.S. adults who are overweight or obese.
Overall, the study findings suggest that semaglutide could be a promising new treatment option for obesity and cardiovascular disease. However, more research is needed to confirm these findings and to determine the long-term safety and efficacy of semaglutide.
Curious about the possibilities of Semaglutide? Our friendly healthcare professionals at Executive Medical are ready to help. Schedule an appointment today and embark on a personalized journey towards your health and wellness objectives. We’re dedicated to providing expert guidance and unwavering support. Reach out to us and take the first step towards a healthier and happier you!